MALIGNANT HYPERTENSION HAMA COHORT: WHERE DO WE STAND IN 2021?
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000838456.70944.4d
Abstract: Objective: Malignant hypertension still exists. It is the deadliest form of hypertension, and has been forgotten. Guidelines are mainly based on consensus, without strong evidence supporting it. French cohort HAMA is the first multicentric nationwide… read more here.
Keywords: hypertension; patients malignant; cohort; malignant hypertension ... See more keywords